The Directory of Pharma Companies and News
With an R&D team in the UK and production through its laboratories and offices in Jiangsu Province, China, LCC’s technologies have been developed through years of research in response to a demand for 'chirally' pure chemicals for use in drugs. The company’s patented methods create exceptionally pure chemical forms using a much cheaper and quicker method compared to incumbents.
LCC’s highly experienced team includes Prof. Jianliang Xiao, who received the 2008 prize for Process Chemistry Research from the Society of Chemistry and Industry having previously worked alongside 2001 Nobel Prize in chemistry winner Prof. Ryoji Noyori, on chiral molecules, and Dr Jianjun Wu who was shortlisted for the Bionow Promising Technologist of the Year Award in 2014.
To date the company has raised £1.1m private equity through VCs and Angel investors, to develop its chemical portfolio and target pharmaceutical R&D companies worldwide. The company counts pharma and biotech companies Merck, Novartis, Domainex, Charles River and Bayer as customers.